NeuroScientific Biopharmaceuticals Limited
NeuroScientific Biopharmaceuticals Limited (NSB.AX) Stock Technical Analysis & Trading Signals
Live technical indicators, trading signals, and momentum insights for NeuroScientific Biopharmaceuticals Limited (ASX:NSB.AX).
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerNSB.AX Technical Analysis Summary
NeuroScientific Biopharmaceuticals Limited stock currently trades in a neutral range, with no clear dominance from buyers or sellers.
Technical conditions suggest NeuroScientific Biopharmaceuticals Limited is consolidating, awaiting a decisive move.
RSI (14): 53.36
Stochastic %K: 90.88
Williams %R: 0.00
Rate of Change (ROC): 7.53
Takeaway:Insufficient data to determine overall momentum trend.
MACD: -0.01
ADX: 32.58
ATR (14): 0.01
CCI (14): 133.16
Takeaway:NeuroScientific Biopharmaceuticals Limited shows weakening trend signals, with bearish pressure building.
Takeaway:NeuroScientific Biopharmaceuticals Limited trades closer to resistance, supported by stronger momentum within bands.
Takeaway:NeuroScientific Biopharmaceuticals Limited trades above the trend line, showing healthy momentum within the channel.
Overall Takeaway:NSB.AX shows bullish money flow, with volume and vigor supporting buyers.
Bullish Signals
RSI above 50 → positive momentum from buyers.
ADX above 20 → strong underlying trend.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
No significant bearish signals detected.
Overall Recommendation:Technical indicators for NeuroScientific Biopharmaceuticals Limited are mixed, suggesting a Hold or wait-and-see approach.